This is Step 2 of a skin lightening treatment for clinical use developed by Dermica Laboratoires Europe. It is a skin whitening formula for application via AMTS (GoldPen), with a slightly acidic pH of around 4.5.This type of treatment has a depigmenting effect, inhibiting the action of tyrosinase, an enzyme involved in the synthesis of melanin, or melanogenesis. Its active ingredients reduce hyperpigmentation, brightening and normalising skin tone.
Aqua, Morus Alba Root Extract, Kojic Acid, Dimethylmethoxy Chromanyl Palmitate, Hydroxypropyl Methylcellulose, Retinyl Palmitate, Glycyrrhiza Glabra Root Extract, Sodium Metabisulfite, Aspergillus Ferment, Disodium EDTA, Alcohol, Ethoxydiglycol, Sodium Hyaluronate, Salicylic Acid, Sorbic Acid
Suitable for use on skin with dark spots, melasma and hyperpigmentation. Not suitable for very dark skin, Fitzpatrick types V and VI. Whitelan provides a newer, brighter complexion, helping regenerate and soften the skin while reducing wrinkles. Treats all kinds of dark spots. Reduces excess melanin production (hyperpigmentation) responsible for the appearance of melasma, chloasma and solar lentigines.
Melasma: General term used to describe discoloured skin patches or spots.
Chloasma: Generally refers to skin discolouration caused by hormonal changes normally occurring during pregnancy, the use of contraceptive pills or oestrogen replacement therapy.
Solar Lentigines: Technical name for skin spots or patches caused by exposure to the sun. This type of skin discolouration is very common in adults with a history of unprotected sun exposure.
Apply using mesotherapy or microneedling (GoldPen) techniques. Pay particular attention to areas with dark spots, chloasma, melasma or solar lentigines. For a general lightening treatment, a single application may be sufficient; in areas with hyperpigmentation problems, a second application will be necessary during treatment.Application can be repeated weekly until the melasma disappears; use of Whitelan Cure Step 3 by the patient at home is recommended. The use of high factor moisturisers and sunscreens is advisable.
The ampoules can be stored at room temperature. Protect from exposure to direct sunlight. Although not essential, it is advisable to keep away from sources of heat. All ampoules have been sterilised.
Exercise caution when applying to patients with very dry skin, dermatitis, eczema, allergic skin conditions or allergy to any of the ingredients.
Possible side effects are mild and transient.
In case of erythema (rash), treat with topical corticosteroids / hydrocortisone and increase moisturisation of the area.